1*5*20 (1 box of 20 Strips of 5 tablets) or 10*10 Blister
All India
WHO-GMP
Product Description
Moxifloxacin has potent activity against Mycobacterium tuberculosis when given with anti-tuberculosis chemotherapy
Much more effective than beta lactamins and macrolildes for the treatment of excerbated COPD
Significantly reduces time to recovery from COPD in patients with moderate to severe disease by approximately 20% (>1day) compared with other antimicrobials
FDA approved bactericidal effective against Mycobacterium leprae thus beneficial in treatment of skin infection